111 (NASDAQ:YI – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.03) EPS for the quarter, FiscalAI reports. The business had revenue of $342.52 million during the quarter.
111 Stock Down 3.3%
YI stock opened at $5.26 on Thursday. The firm has a market cap of $46.24 million, a PE ratio of -5.26 and a beta of 0.60. The business has a 50 day moving average of $6.18 and a 200-day moving average of $5.61. 111 has a 12-month low of $2.48 and a 12-month high of $11.17.
Analysts Set New Price Targets
Separately, Weiss Ratings raised 111 from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, May 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.
About 111
111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.
111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.
Featured Stories
- Five stocks we like better than 111
- Dell’s AI Toll Bridge Is Paved with Record Margins
- As AI Data Breaches Become More Common, This Cybersecurity ETF Is SurgingAI
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
